News & Updates
Showing Multidisciplinary articles
Showing
IMDC score, metastatic sites predict survival in mRCC patients undergoing surveillance
Surveillance of favourable-risk patients with metastatic renal cell carcinoma (mRCC) using risk stratification based on the International mRCC Database Consortium (IMDC) and number of metastatic sites may be done following cytoreductive nephrectomy without initiating systemic therapy, suggests a recent study.
IMDC score, metastatic sites predict survival in mRCC patients undergoing surveillance
30 Jul 2023
Financial toxicity in prostate cancer means less spending on basic goods, leisure
Patients with metastatic prostate cancer who report high financial toxicity tend to spend less on basic goods and leisure activity and use their savings to pay for care, according to the results of a cross-sectional study.
Financial toxicity in prostate cancer means less spending on basic goods, leisure
29 Jul 2023
Which parameters predict sacral neuromodulation outcomes?
Some parameters that are usually assessed intraoperatively during stage 1 sacral neuromodulation appear to be of little use in predicting acute and long-term outcomes in urgency urinary incontinence, reveals a study.
Which parameters predict sacral neuromodulation outcomes?
28 Jul 2023
Integrated analysis supports long-term efficacy of ritlecitinib for alopecia areata
An integrated analysis of the pivotal phase IIb/III ALLEGRO and phase III ALLEGRO-LT studies demonstrated the long-term efficacy of the oral JAK3/TEC family kinase inhibitor ritlecitinib for alopecia areata (AA).
